Immune Enhancement of Yellow Fever Virus Neurovirulence for Mice: Studies of (original) (raw)

Immune Enhancement of Yellow Fever Virus Neurovirulence for Mice: Studies of Mechanisms Involved

Ernest Gould

Journal of General Virology, 1988

View PDFchevron_right

Antibody-dependent Enhancement of Yellow Fever and Japanese Encephalitis Virus Neurovirulence

Ernest Gould

Journal of General Virology, 1989

View PDFchevron_right

Neutralizing (54K) and Non-neutralizing (54K and 48K) Monoclonal Antibodies against Structural and Non-structural Yellow Fever Virus Proteins Confer Immunity in Mice

Ernest Gould

Journal of General Virology, 1986

View PDFchevron_right

Antibody-mediated Early Death in vivo after Infection with Yellow Fever Virus

Ernest Gould

Journal of General Virology, 1986

View PDFchevron_right

Reduction of Yellow Fever Virus Mouse Neurovirulence by Immunization with a Bacterially Synthesized Non-structural Protein (NS1) Fragment

Ernest Gould

Journal of General Virology, 1988

View PDFchevron_right

Yellow fever 17-D vaccine is neurotropic and produces encephalitis in immunosuppressed hamsters

Robert Tesh

The American journal of tropical medicine and hygiene, 2007

View PDFchevron_right

CD8+ T Cells Complement Antibodies in Protecting against Yellow Fever Virus

Christina Fenger, Jan Christensen, Allan R Thomsen

Journal of immunology (Baltimore, Md. : 1950), 2015

View PDFchevron_right

A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection

Mikhail Khoretonenko

PLoS Pathogens, 2009

View PDFchevron_right

Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice

John Mackenzie

Journal of General Virology, 2003

View PDFchevron_right

Importance of the Antibody Response in the Outcome of Virus-Induced Diseases of the Central Nervous System

Robert Knobler

Viruses, Immunity, and Mental Disorders, 1987

View PDFchevron_right

Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys

Marcos Freire, Renato Marchevsky

Virology, 2003

View PDFchevron_right

Intrathecal antibody production in two cases of yellow fever vaccine associated neurotropic disease in Argentina

Corina Nemirovsky

Journal of Medical Virology, 2011

View PDFchevron_right

Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies

Junko Kimura-Kuroda

Journal of Immunology, 1988

View PDFchevron_right

Antigenic analysis of yellow fever virus glycoproteins: Use of monoclonal antibodies in enzyme-linked immunosorbent assays

Ernest Gould

Journal of Virological Methods, 1986

View PDFchevron_right

Experimental Yellow Fever Virus Infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, Biochemical, and Immunologic Studies

Robert Tesh

The Journal of Infectious Diseases, 2001

View PDFchevron_right

Neutralizing and Non-neutralizing Monoclonal Antibodies to the E2 Glycoprotein of Semliki Forest Virus Can Protect Mice from Lethal Encephalitis

M. Harmsen

Journal of General Virology, 1983

View PDFchevron_right

CD8+ T cells complement antibodies in protection against yellow fever virus

Michael Rasmussen, Maria Bassi, Jan Christensen

View PDFchevron_right

Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses

Robert Tesh

The American journal of tropical medicine and hygiene, 2003

View PDFchevron_right

Increased cellular immunity against host cell antigens induced by vacciniavirus

Ulrich Koszinowski

Archiv f�r die gesamte Virusforschung, 1974

View PDFchevron_right

Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain

Veronique Barban

Biologicals, 2013

View PDFchevron_right

Immunity and immune response, pathology and pathologic changes: progress and challenges in the immunopathology of yellow fever

Carla Pagliari

Reviews in Medical Virology, 2013

View PDFchevron_right

Antibody-mediated clearance of viruses from the mammalian central nervous system

Bernhard F Dietzschold

Trends in Microbiology, 1993

View PDFchevron_right

Neurotropism of Swine Haemagglutinating Encephalomyelitis Virus (Coronavirus) in Mice Depending upon Host Age and Route of Infection

Koujiro Tohyama

Journal of Comparative Pathology, 2004

View PDFchevron_right

Replication of virulent and attenuated strains of yellow fever virus in human monocytes and macrophage-like cells (U937)

Ferdinando Liprandi

Archives of Virology, 1983

View PDFchevron_right

The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus

Harm Snippe

Immunology, 1986

View PDFchevron_right

A Japanese Encephalitis Virus Vaccine Inducing Antibodies Strongly Enhancing In Vitro Infection Is Protective in Pigs

Meret Ricklin

Viruses, 2017

View PDFchevron_right

Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses

Ernest Gould

Archives of Virology, 1991

View PDFchevron_right

Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model

SHAIKH TERKIS ISLAM PAVEL

View PDFchevron_right

Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys

Marcos Freire

Brazilian Journal of Medical and Biological Research, 2005

View PDFchevron_right

Viruses and antibody response: An update

P L Ogra

Clinical Immunology Newsletter, 1985

View PDFchevron_right

An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures

Marcos Freire

Vaccine, 2015

View PDFchevron_right

Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever Vaccination

ricardo caminha

Clinical and Vaccine Immunology, 2009

View PDFchevron_right